Table 2. Changes in SZ patients before and after the treatment.
| SZ before treatment (m±s.d.) | SZ after treatment (m±s.d.) | One-tailed P-value | |
|---|---|---|---|
| Weight (kg) | 82.00±16.76 | 83.52±15.93 | 0.03 |
| TFEQ | |||
| Factor 1 | 8.60±3.83 | 8.40±3.83 | 0.32 |
| Factor 2 | 5.46±2.69 | 5.46±2.85 | 0.27 |
| Factor 3 | 4.06±2.84 | 4.13±3.04 | 0.27 |
| PANSS, positive | 20.80±5.79 | 18.53±4.95 | 0.03 |
| PANSS, negative | 18.06±4.21 | 18.53±5.05 | 0.47 |
| PANSS, general | 39.26±9.36 | 36.53±10.93 | 0.16 |
| PANSS, total | 78.13±15.05 | 73.60±18.93 | 0.19 |
| Glucose (mmol l−1) | 4.90±0.49 | 5.05±1.02 | 0.07 |
| Cholesterol (mmol l−1) | 4.31±1.09 | 4.45±0.54 | 0.21 |
| Triglyceride (mmol l−1) | 1.10±0.74 | 1.37±0.88 | 0.03 |
| HDL (mmol l−1) | 1.16±0.24 | 1.17±0.34 | 0.47 |
| LDL (mmol l−1) | 2.65±0.97 | 2.65±0.54 | 0.41 |
| Chol LDL | 3.98±1.62 | 4.00±1.22 | 0.28 |
| Insulin (pmol l−1) | 45.06±30.45 | 74.76±49.72 | 0.008 |
| Prolactin (μg l−1) | 27.98±51.13 | 16.12±10.33 | 0.45 |
| Leptin (ng ml−1) | 9.17±14.08 | 11.71±12.9 | 0.02 |
| Ghrelin (pg ml−1) | 1062.46±379.33 | 989.09±380.85 | 0.04 |
Abbreviations: HDL, high-density lipoprotein; LDL, low-density lipoprotein; PANSS, Positive and Negative Symptoms Scale; SZ, schizophrenic; TFEQ, Three-Factor Eating Questionnaire.
Bold indicates significant differences pre- to post-treatment (P<0.05, one-tailed), measured with Wilcoxon's signed-rank test.